Research in gene therapy for for age-related macular degeneration

Speaker: Dr. Thomas A. Ciulla

Gene therapy holds promise as a transformative approach in the treatment of age-related macular degeneration. It offers potential advantages of reduced treatment frequency and enhanced safety. Advancements in gene therapy hold promise for improving patient outcomes and providing new treatments of diabetic eye diseases.

Dr. Thomas Ciulla graduated with high honors from Harvard College and earned his medical degree from the University of California. He completed his residency at Harvard Medical School and then a fellowship at Tufts Medical School, where he received the prestigious Heed Fellowship. Before joining the Midwest Eye Institute here in Carmel, Dr. Ciulla served on the faculty of the Indiana University School of Medicine.

A nationally recognized expert in diseases of the eye, Dr. Ciulla has:

• participated in more than 100 clinical trials,
• served on numerous advisory and editorial boards,
• edited medical textbooks,
• presented at more than 200 conferences, and
• authored over 130 peer-reviewed scientific papers.

Sponsored by John Prentice